The stability of norfloxacin in an extemporaneously prepared suspension stored at room temperature and under refrigeration was studied over 56 days. A 20-mg/mL suspension was prepared from commercially available 400-mg norfloxacin tablets and equal amounts of Ora-Plus and strawberry syrup to make a final volume of 60 mL. Six identical samples of the suspension were prepared in amber plastic prescription bottles. Three were stored at room temperature (23-25 degrees C) and three under refrigeration (3-5 degrees C). Immediately after preparation and at 7, 14, 28, and 56 days, the samples were assayed in duplicate by stability-indicating high performance liquid chromatography. The samples were also inspected for color and odor changes and the pH of each sample was determined. At least 93% of the initial norfloxacin concentration remained throughout the 56-day study period. The color, odor, and pH of all of the samples did not change appreciably. An extemporaneously prepared suspension of norfloxacin 20 mg/mL was stable for at least 56 days when stored at either 23-25 or 3-5 degrees C.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/ajhp/58.7.577 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessment of patients' perception and satisfaction with extemporaneous compounding service in ALERT hospital, Ethiopia.
BMC Health Serv Res
January 2025
Department of Pharmaceutics and Social Pharmacy, School of Pharmacy, Addis Ababa University, P.O. Box 1176, Addis Ababa, Ethiopia.
Background: Extemporaneous compounding for dermatological use is an important therapeutic alternative for patients whose clinical needs are not met by approved drug products circulated in the market. Evaluating patients' perceptions and levels of satisfaction towards such services is an important factor for the adherence of patients and maintaining the quality of healthcare services. The current study aimed to assess patients' perception and level of satisfaction with the compounding service and extemporaneous preparations rendered at ALERT hospital.
View Article and Find Full Text PDFPhysicochemical and Microbiological Stability of Ursodiol Oral Compounded Suspensions.
J Pediatr Pharmacol Ther
December 2024
Research and Development (KI, MC), PCCA, Houston, TX.
Objective: In the United States, ursodiol is commercially available as solid dosage forms, which represents a problem for children who cannot swallow capsules or tablets. There is a lack of an age-appropriate formulation for ursodiol, and the extemporaneous preparation of an oral suspension with an extended beyond-use-date (BUD) may represent a good therapeutic alternative for the pediatric population. However, all pharmacists need validated stability studies to prepare oral liquids with high quality and safety.
View Article and Find Full Text PDFExtemporaneous Compounding of Medicated Ointments.
Int J Pharm Compd
December 2024
Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois.
Article Synopsis
- Topical preparations, especially in dermatology, account for a significant portion of compounded prescriptions and involve varied ointment bases with active ingredients often added in liquid forms.
- There are currently no established quantitative guidelines on how different ointment bases absorb water and alcohol, prompting a short experiment to measure their capacity for these solvents.
- The findings aim to help compounding pharmacists choose the most appropriate base based on the solvent requirements for effective topical medications, while also offering insights into compounding challenges related to these preparations.
Article Synopsis
- Chloral hydrate is a sedative used mainly in children for procedures like dental sedation and can be adapted for different patient needs due to a lack of commercially available age-appropriate forms.
- Researchers created a customizable oral liquid formulation of chloral hydrate using a suspending vehicle called PCCA SuspendIt, which is free from sugar, dyes, and gluten, to improve dosing accuracy for both pediatric and adult patients.
- The study aimed to develop and validate a stability-indicating assay using ultra-high-performance liquid chromatography (UPLC) to ensure the chemical stability of chloral hydrate at varying concentrations.
Pediatric Orally Disintegrating Tablets (ODTs) with Enhanced Palatability Based on Propranolol HCl Coground with Hydroxypropyl-β-Cyclodextrin.
Pharmaceutics
October 2024
Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, 20133 Milan, Italy.
Background: Propranolol, largely prescribed as an antihypertensive and antiarrhythmic drug in pediatrics, is characterized by a bitter taste and an astringent aftertaste. Currently, the therapy requires crushing of tablets for adults and their dispersion in water many times a day, leading to loss of dosing accuracy, low palatability, and poor compliance for both patients and caregivers.
Objectives: This work aimed to exploit cyclodextrin complexation by cogrinding to develop orally disintegrating tablets (ODTs) endowed with reliable dosing accuracy, good palatability and safety, ease of swallowability, and ultimately better compliance for both pediatric patients and caregivers.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!